MarketPeel
Insider Trading Intelligence
Pricing
…
PC

Pad Chivukula

ARCT
CHIEF SCIENTIFIC OFFICER & COO · ARCTURUS THERAPEUTICS HOLDINGS INC. · CIK 0001727317
FILING MIX · LIFETIME18%/82%
BUYS
7
SELLS
31
TOTAL VALUE
$12.01M
COMPANIES
1
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
54,000
AVG SELL PX
$41.11
TRADE KIND
SHOWING 38 / 38
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
31 backtested trades · 8 horizons · 1 pending
Forward-return performance of every backtestable P/S trade by Pad Chivukula, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d31+74.19%-4.63%+0.69%-5.32%-5.43%-1.85
14d31+67.74%-3.16%+1.34%-4.50%-6.24%-1.37
30d31+67.74%-7.00%+1.17%-8.17%-14.20%-1.58
60d31+74.19%-7.99%+2.64%-10.63%-15.70%-1.62
90d31+70.97%-9.27%+5.13%-14.39%-23.65%-2.08
180d31+77.42%-22.28%+7.54%-29.82%-43.67%-4.56
1y31+80.65%-26.75%+15.70%-42.45%-46.07%-6.18
2y31(1 pending)+96.67%-55.11%+24.26%-78.48%-80.16%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ARCT · 54,000 shares · as of Dec 17, 2025
0180,637361,274541,911722,54820212022202320242025SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
FLOW · 7 buys / 31 sellsCOVERAGE · 24 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
PURCHASEGRANT
Stock grant
54,000——54,000Dec 17, 2025Dec 19, 2025 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
PURCHASEGRANT
Stock grant
60,000——60,000Dec 16, 2024Dec 18, 2024 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
SALE10b5-1
10b5-1 plan
12,000$20.76$249.1K435,334Oct 15, 2024Oct 16, 2024 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
SALE10b5-1
10b5-1 plan
114$45.00$5.1K447,334Jun 5, 2024Jun 7, 2024 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
SALE10b5-1
10b5-1 plan
26,000$40.01$1.04M447,448Jun 3, 2024Jun 4, 2024 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
SALE10b5-1
10b5-1 plan
17,435$35.02$610.6K473,448Mar 25, 2024Mar 27, 2024 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
SALE10b5-1
10b5-1 plan
8,565$35.01$299.8K490,883Mar 19, 2024Mar 21, 2024 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
PURCHASEGRANT
Stock grant
125,000——125,000Dec 15, 2023Dec 19, 2023 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
SALE10b5-1
10b5-1 plan
5,000$18.72$93.6K499,448Nov 1, 2023Nov 3, 2023 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
SALE10b5-1
10b5-1 plan
5,000$25.61$128.1K504,448Oct 2, 2023Oct 4, 2023 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
SALE10b5-1
10b5-1 plan
5,000$31.45$157.3K509,448Sep 1, 2023Sep 5, 2023 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
SALE10b5-1
10b5-1 plan
5,000$34.91$174.6K514,448Aug 1, 2023Aug 3, 2023 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
SALE10b5-1
10b5-1 plan
25,000$35.01$875.3K519,448Jul 14, 2023Jul 18, 2023 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
SALE10b5-1
10b5-1 plan
5,000$27.16$135.8K549,448Jun 1, 2023Jun 5, 2023 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
SALE10b5-1
10b5-1 plan
7,925$30.24$239.7K554,448May 11, 2023May 12, 2023 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
SALE10b5-1
10b5-1 plan
17,075$30.00$512.3K562,373May 10, 2023May 12, 2023 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
SALE10b5-1
10b5-1 plan
5,000$25.93$129.7K579,448May 1, 2023May 3, 2023 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
SALE10b5-1
10b5-1 plan
5,000$25.38$126.9K584,448Apr 3, 2023Apr 5, 2023 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
SALE
Chief Scientific Officer & COO
5,000$16.07$80.3K589,448Mar 6, 2023Mar 8, 2023 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
PURCHASEGRANT
Stock grant
125,000——125,000Dec 9, 2022Dec 13, 2022 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
PURCHASEGRANT
Stock grant
85,000——85,000Jun 21, 2022Jun 23, 2022 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
SALE
Chief Scientific Officer & COO
8,100$40.00$324.0K594,448Jan 4, 2022Jan 6, 2022 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
SALE
Chief Scientific Officer & COO
3,633$40.00$145.3K602,548Dec 16, 2021Dec 20, 2021 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
SALE
Chief Scientific Officer & COO
6,367$40.00$254.7K606,181Dec 8, 2021Dec 10, 2021 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
SALE
Chief Scientific Officer & COO
10,000$44.41$444.1K612,548Nov 1, 2021Nov 3, 2021 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
SALE
Chief Scientific Officer & COO
10,000$44.36$443.6K622,548Oct 1, 2021Oct 4, 2021 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
SALE
Chief Scientific Officer & COO
10,000$55.86$558.6K632,548Sep 1, 2021Sep 2, 2021 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
SALE
Chief Scientific Officer & COO
10,000$40.07$400.7K642,548Aug 3, 2021Aug 5, 2021 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
SALE
Chief Scientific Officer & COO
10,000$42.95$429.5K652,548Apr 1, 2021Apr 5, 2021 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
SALE
Chief Scientific Officer & COO
10,000$54.23$542.3K662,548Mar 1, 2021Mar 3, 2021 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
SALE
Chief Scientific Officer & COO
10,000$75.31$753.1K672,548Feb 1, 2021Feb 3, 2021 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
SALE
Chief Scientific Officer & COO
10,000$46.40$464.0K682,548Jan 4, 2021Jan 5, 2021 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
PURCHASEGRANT
Stock grant
100,000——100,000Dec 18, 2020Dec 22, 2020 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
SALE
Chief Scientific Officer & COO
10,000$96.19$961.9K692,548Dec 1, 2020Dec 3, 2020 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
SALE
Chief Scientific Officer & COO
10,000$55.28$552.8K702,548Nov 2, 2020Nov 3, 2020 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
SALE
Chief Scientific Officer & COO
10,000$42.83$428.3K712,548Oct 1, 2020Oct 2, 2020 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
SALE
Chief Scientific Officer & COO
10,000$45.16$451.6K722,548Sep 3, 2020Sep 4, 2020 ↗View →
ARCT
ARCTURUS THERAPEUTICS HOLDINGS INC.
PURCHASEGRANT
Stock grant
60,000——60,000Feb 18, 2020Feb 20, 2020 ↗View →
Other insiders · ARCT
Loading peer insiders…
About this filer
CIK 0001727317
ROLE
Chief Scientific Officer & COO
PRIMARY
ARCT
COMPANIES
1
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001727317DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback